Skip to main content

Advertisement

Log in

MRI features of benign peripheral nerve sheath tumors: how do sporadic and syndromic tumors differ?

  • Scientific Article
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

Abstract

Objectives

To compare MRI features of sporadic and neurofibromatosis syndrome–related localized schwannomas and neurofibromas.

Methods

In this retrospective study, our pathology database was searched for “neurofibroma” or “schwannoma” from 2014 to 2019. Exclusion criteria were lack of available MRI and intradural or plexiform tumors. Qualitative and quantitative anatomic (location, size, relationship to nerve, signal, muscle denervation) and functional (arterial enhancement, apparent diffusion-weighted coefficient) MRI features of sporadic and syndrome-related tumors were compared. Statistical significance was assumed for p < 0.05.

Results

A total of 80 patients with 64 schwannomas (sporadic: 42 (65.6%) v. syndrome-related: 22 (34.4%)) and 19 neurofibromas (sporadic: 7 (36.8%) v. syndrome-related: 12 (41.7%)) were included. Only signal heterogeneity (T2W p=0.001, post-contrast p=0.03) and a diffused-weighted imaging target sign (p=0.04) were more frequent with schwannomas than neurofibromas. Sporadic schwannomas were similar in size to syndrome-related schwannomas (2.9±1.2cm vs. 3.7±3.2 cm, p = 0.6), but with greater heterogeneity (T2W p = 0.02, post-contrast p = 0.01). Sporadic neurofibromas were larger (4.6±1.5cm vs. 3.4±2.4 cm, p = 0.03) than syndrome-related neurofibromas, also with greater heterogeneity (T2W p=0.03, post-contrast p=0.04). Additional tumors along an affected nerve were only observed with syndrome-related tumors). There was no difference in apparent diffusion coefficient values or presence of early perfusion between sporadic and syndrome-related tumors (p > 0.05).

Conclusions

Although syndrome-related and sporadic schwannomas and neurofibromas overlap in their anatomic, diffusion and perfusion features, signal heterogeneity and presence of multiple lesions along a nerve are differentiating characteristics of syndrome-related tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data Availability

The data that support the findings of this study are available from the corresponding author, P.D., upon reasonable request.

References

  1. Murphey MD, Smith WS, Smith SE, Kransdorf MJ, Temple HT. From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics. 1999;19:1253–80.

    Article  CAS  PubMed  Google Scholar 

  2. Kim DH, Murovic JA, Tiel RL, Moes G, Kline DG. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center. J Neurosurg. 2005;102:246–55.

    Article  PubMed  Google Scholar 

  3. Neurofibroma - an overview | ScienceDirect Topics. [cited 2023 Sep 4]. Available from: https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/neurofibroma. Accessed 4 Sept 2023.

  4. Rodriguez FJ, Folpe AL, Giannini C, Perry A. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol. 2012;123:295–319.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Zhang M, Tong E, Wong S, Hamrick F, Mohammadzadeh M, Rao V, et al. Machine learning approach to differentiation of peripheral schwannomas and neurofibromas: a multi-center study. Neuro Oncol. 2022;24:601–9.

    Article  PubMed  Google Scholar 

  6. Caltabiano R, Magro G, Polizzi A, Praticò AD, Ortensi A, D’Orazi V, et al. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas. Childs Nerv Syst. 2017;33:933–40.

    Article  PubMed  Google Scholar 

  7. Plotkin SR, Wick A. Neurofibromatosis and Schwannomatosis. Semin Neurol. 2018;38:73–85.

    Article  PubMed  Google Scholar 

  8. Ahlawat S, Blakeley JO, Langmead S, Belzberg AJ, Fayad LM. Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Skeletal Radiol. 2020;49:199–219.

    Article  PubMed  Google Scholar 

  9. Belakhoua SM, Rodriguez FJ. Diagnostic pathology of tumors of peripheral nerve. Neurosurgery. 2021;88:443–56.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ahlawat S, Baig A, Blakeley JO, Jacobs MA, Fayad LM. Multiparametric whole-body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis. J Magn Reson Imaging. 2016;44:794–803.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Gunasekaran A, Newhart H, Kumar M, Kazemi N. Utility of MRI neurography in neurofibromatosis type I: case example and review of MRI neurography literature. Surg Neurol Int. 2019;10:12.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Salamon J, Veldhoen S, Apostolova I, Bannas P, Yamamura J, Herrmann J, et al. 18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off. Eur Radiol. 2014;24:405–12.

    Article  PubMed  Google Scholar 

  13. Schwabe M, Spiridonov S, Yanik EL, Jennings JW, Hillen T, Ponisio M, et al. How effective are noninvasive tests for diagnosing malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1? Diagnosing MPNST in NF1 patients. Sarcoma. 2019;2019:4627521.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Plotkin SR, Blakeley JO, Evans DG, Hanemann CO, Hulsebos TJM, Hunter-Schaedle K, et al. Update from the 2011 International Schwannomatosis Workshop: from genetics to diagnostic criteria. Am J Med Genet A. 2013;0:405–16.

    Article  PubMed Central  Google Scholar 

  15. Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, et al. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation. Genet Med. 2022;24:1967–77.

    Article  CAS  PubMed  Google Scholar 

  16. Lin J, Martel W. Cross-sectional imaging of peripheral nerve sheath tumors: characteristic signs on CT, MR imaging, and sonography. AJR Am J Roentgenol. 2001;176:75–82.

    Article  CAS  PubMed  Google Scholar 

  17. Lee SK, Kim J-Y, Jeong HS. Benign peripheral nerve sheath tumor of digit versus major-nerve: comparison of MRI findings. PLoS One. 2020;15:e0230816.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Ahlawat S, Fayad LM. Imaging cellularity in benign and malignant peripheral nerve sheath tumors: utility of the “target sign” by diffusion weighted imaging. Eur J Radiol. 2018;102:195–201.

    Article  PubMed  Google Scholar 

  19. Zipfel J, Al-Hariri M, Gugel I, Grimm A, Steger V, Ladurner R, et al. Surgical management of sporadic peripheral nerve schwannomas in adults: indications and outcome in a single center cohort. Cancers (Basel). 2021;13:1017.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Hilton DA, Hanemann CO. Schwannomas and their pathogenesis. Brain Pathol. 2014;24:205–20.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Debs P, Fayad LM, Ahlawat S. MR neurography of peripheral nerve tumors and tumor-mimics. Semin Roentgenol. 2022;57:232–40.

    Article  PubMed  Google Scholar 

  22. Ogose A, Hotta T, Morita T, Yamamura S, Hosaka N, Kobayashi H, et al. Tumors of peripheral nerves: correlation of symptoms, clinical signs, imaging features, and histologic diagnosis. Skeletal Radiol. 1999;28:183–8.

    Article  CAS  PubMed  Google Scholar 

  23. Fayad LM, Blakeley J, Plotkin S, Widemann B, Jacobs MA. Whole body MRI at 3T with quantitative diffusion weighted imaging and contrast-enhanced sequences for the characterization of peripheral lesions in patients with neurofibromatosis type 2 and Schwannomatosis. ISRN Radiol. 2013;2013:627932.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Yun JS, Lee MH, Lee SM, Lee JS, Kim HJ, Lee SJ, et al. Peripheral nerve sheath tumor: differentiation of malignant from benign tumors with conventional and diffusion-weighted MRI. Eur Radiol. 2021;31:1548–57.

    Article  PubMed  Google Scholar 

  25. Li C-S, Huang G-S, Wu H-D, Chen W-T, Shih L-S, Lii J-M, et al. Differentiation of soft tissue benign and malignant peripheral nerve sheath tumors with magnetic resonance imaging. Clin Imaging. 2008;32:121–7.

    Article  PubMed  Google Scholar 

  26. Soldatos T, Fisher S, Karri S, Ramzi A, Sharma R, Chhabra A. Advanced MR imaging of peripheral nerve sheath tumors including diffusion imaging. Semin Musculoskelet Radiol. 2015;19:179–90.

    Article  PubMed  Google Scholar 

  27. Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD. MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol. 1997;27:124–9.

    Article  CAS  PubMed  Google Scholar 

  28. Jee W-H, Oh S-N, McCauley T, Ryu K-N, Suh J-S, Lee J-H, et al. Extraaxial neurofibromas versus neurilemmomas: discrimination with MRI. AJR Am J Roentgenol. 2004;183:629–33.

    Article  PubMed  Google Scholar 

  29. Söderlund V, Göranson H, Bauer HCF. MR imaging of benign peripheral nerve sheath tumors. Acta Radiol. 1994;35:282–6.

    Article  PubMed  Google Scholar 

  30. Kakkar C, Shetty CM, Koteshwara P, Bajpai S. Telltale signs of peripheral neurogenic tumors on magnetic resonance imaging. Indian J Radiol Imaging. 2015;25:453–8.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Stull MA, Moser RP, Kransdorf MJ, Bogumill GP, Nelson MC. Magnetic resonance appearance of peripheral nerve sheath tumors. Skeletal Radiol. 1991;20:9–14.

    Article  CAS  PubMed  Google Scholar 

  32. Lee SK, Kim J-Y, Lee Y-S, Jeong HS. Intramuscular peripheral nerve sheath tumors: schwannoma, ancient schwannoma, and neurofibroma. Skeletal Radiol. 2020;49:967–75.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrick Debs.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Debs, P., Luna, R., Fayad, L.M. et al. MRI features of benign peripheral nerve sheath tumors: how do sporadic and syndromic tumors differ?. Skeletal Radiol 53, 709–723 (2024). https://doi.org/10.1007/s00256-023-04479-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-023-04479-1

Keywords

Navigation